To demonstrate that IL-6 was also a direct downstream target of NF-κB in HCC cells, we treated SMMC-7721 and BEL-7402 with NF-κB inhibitor BAY 11-7082 for a short period of time (4 hours). Here, NFKB1 is linked to hepatocellular carcinoma.